Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto D'Angelo

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
Journal of Clinical Medicine|May 15, 2020
MSI and EBV Positive Gastric Cancer's Subgroups and Their Link With Novel ImmunotherapyMaria Grazia Rodriquenz, Giandomenico Roviello, Alberto D'Angelo, et al.
Clinical Medicine Insights. Oncology|October 28, 2025
Navigating Cancer Complexity: Integrative Multi-Omics Methodologies for Clinical InsightsMartina Catalano, Alberto D'Angelo, Francesco De Logu, et al.
Molecules (Basel, Switzerland)|October 23, 2021
p53 Antibodies as a Diagnostic Marker for Cancer: A Meta-AnalysisNavid Sobhani, Giandomenico Roviello, Alberto D'Angelo, et al.
Investigational New Drugs|January 21, 2021
Advances in anti-BRAF therapies for lung cancerGiandomenico Roviello, Alberto D'Angelo, Marianna Sirico, et al.
International Journal of Molecular Sciences|June 12, 2020
Mutant p53 as an Antigen in Cancer ImmunotherapyNavid Sobhani, Alberto D'Angelo, Xu Wang, et al.
Expert Review of Clinical Pharmacology|March 9, 2021
Darolutamide in hormone-sensitive and castration-resistant prostate cancerValeria Emma Palmieri, Giandomenico Roviello, Alberto D'Angelo, et al.
Cancer Chemotherapy and Pharmacology|August 11, 2022
An update on antibody-drug conjugates in urothelial carcinoma: state of the art strategies and what comes nextAlberto D'Angelo, Robert Chapman, Marianna Sirico, et al.
Stem Cell Reviews and Reports|October 21, 2024
Patient-Derived Organoids: A Game-Changer in Personalized Cancer MedicineMohammad Hadi Abbasian, Navid Sobhani, Mahsa Mollapour Sisakht, et al.
Critical Reviews in Oncology/Hematology|June 11, 2020
TRK fusion positive cancers: From first clinical data of a TRK inhibitor to future directionsGiandomenico Roviello, Alberto D'Angelo, Marianna Sciortino, et al.
Immunotherapy|April 5, 2022
Immune checkpoint inhibitor-induced neurologic toxicity: a case report and literature reviewValeria Emma Palmieri, Giandomenico Roviello, Martina Catalano, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Journal of Clinical Medicine|May 15, 2020
MSI and EBV Positive Gastric Cancer's Subgroups and Their Link With Novel ImmunotherapyMaria Grazia Rodriquenz, Giandomenico Roviello, Alberto D'Angelo, et al.
Clinical Medicine Insights. Oncology|October 28, 2025
Navigating Cancer Complexity: Integrative Multi-Omics Methodologies for Clinical InsightsMartina Catalano, Alberto D'Angelo, Francesco De Logu, et al.
Molecules (Basel, Switzerland)|October 23, 2021
p53 Antibodies as a Diagnostic Marker for Cancer: A Meta-AnalysisNavid Sobhani, Giandomenico Roviello, Alberto D'Angelo, et al.
Investigational New Drugs|January 21, 2021
Advances in anti-BRAF therapies for lung cancerGiandomenico Roviello, Alberto D'Angelo, Marianna Sirico, et al.
International Journal of Molecular Sciences|June 12, 2020
Mutant p53 as an Antigen in Cancer ImmunotherapyNavid Sobhani, Alberto D'Angelo, Xu Wang, et al.
Expert Review of Clinical Pharmacology|March 9, 2021
Darolutamide in hormone-sensitive and castration-resistant prostate cancerValeria Emma Palmieri, Giandomenico Roviello, Alberto D'Angelo, et al.
Cancer Chemotherapy and Pharmacology|August 11, 2022
An update on antibody-drug conjugates in urothelial carcinoma: state of the art strategies and what comes nextAlberto D'Angelo, Robert Chapman, Marianna Sirico, et al.
Stem Cell Reviews and Reports|October 21, 2024
Patient-Derived Organoids: A Game-Changer in Personalized Cancer MedicineMohammad Hadi Abbasian, Navid Sobhani, Mahsa Mollapour Sisakht, et al.
Critical Reviews in Oncology/Hematology|June 11, 2020
TRK fusion positive cancers: From first clinical data of a TRK inhibitor to future directionsGiandomenico Roviello, Alberto D'Angelo, Marianna Sciortino, et al.
Immunotherapy|April 5, 2022
Immune checkpoint inhibitor-induced neurologic toxicity: a case report and literature reviewValeria Emma Palmieri, Giandomenico Roviello, Martina Catalano, et al.
Pageof 6